Scientific Officer - Target Validation and DNA Damage Response Team (Prof Andrew Tutt)

Key Information

Salary: Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review. 

This role is eligible for ICR Sponsorship.  Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here. 

Duration of Contract: Fixed Term until 31 July 2025

Hours per week: 35 hours per week (Full Time)

Closing Date: Sunday 8th October 2023  

Job Details

Under the leadership of Professor Andrew Tutt, we are seeking to appoint a Scientific Officer to provide technical support for projects running in the Target Validation and DNA Damage Response laboratory. The majority of these projects focus on identifying and validating biomarkers and relevant therapy targets in breast cancer and studying the underlying biology of the disease. There is a particular focus on triple-negative breast cancer and breast cancers with defects in DNA repair and genome instability.  The laboratory has access to patient material, including a unique collection of breast cancer organoid models.

The successful candidate will assist with a variety of molecular biology, cell culture and DNA repair assays, as well as assisting with the smooth running of the laboratory in general.

Key Requirements

Applicants should have a BSc in molecular and cellular biology (or equivalent qualification) and cell culture skills, especially with organoid models would be an advantage. 

Department/Directorate Information

The Target Validation and DNA Damage Response team, lead by Professor Andrew Tutt, interests involve the discovery of novel therapies and biomarkers in BRCA1/BRCA2-associated cancers and ER/HER2-negative/basal-like breast cancers – including the identification of new drug targets and therapy combination strategies.

The Breast Cancer Now Toby Robins Research Centre at the ICR is the first centre in the UK entirely devoted to breast cancer research.  Our goal is to advance research into the causes, diagnosis and treatment of breast cancer.  It is located in state-of-the-art laboratory space with excellent core facilities and funding.  The Research Centre with its collaborators at the Royal Marsden Hospital recently won the AACR 2022 Team Science Award for its impact through research on the care of women with breast cancer.  

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here. 

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.

Advert information